⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SVRA News
Savara Inc.
PANTHERx ® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*
businesswire.com
SVRA
Savara Announces Participation in the 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
SVRA
Bronstein, Gewirtz & Grossman, LLC Is Investigating Savara Inc. (SVRA) And Encourages Shareholders to Connect
accessnewswire.com
SVRA
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Savara Inc. (SVRA) And Encourages Shareholders to Reach Out
accessnewswire.com
SVRA
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Savara Inc. (SVRA) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
SVRA
Lifshitz Law PLLC Announces Investigations of Cytokinetics, Incorporated (NASDAQ: CYTK), Fly-E Group, Inc. (NASDAQ: FLYE), Lantheus Holdings, Inc. (NASDAQ: LNTH), and Savara Inc. (NASDAQ: SVRA)
accessnewswire.com
CYTK
FLYE
LNTH
SVRA
Savara Inc. (SVRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
SVRA
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Savara Inc. (SVRA) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
SVRA
Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow ® Nebulizer System
businesswire.com
SVRA
Savara Inc. (SVRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
SVRA